A major obstacle on the path to diagnosis of endometriosis is the high rate of misdiagnosis, often caused by misleading symptoms. Endometriosis symptoms can mimic other conditions like IBS or bladder problems, leading to misdiagnoses and delayed or unnecessary treatments.

The search for answers often involves seeing multiple specialists, each with a specific focus. Being referred to the wrong specialist can result in inaccurate treatment. Repeated doctor visits without a diagnosis or effective treatment can lead to frustration, a feeling of not being heard, and ultimately, a breakdown in trust between patient and health care providers.

By promoting multidisciplinary care, we can empower women with endometriosis to navigate the maze and find the path to better health.

Gesynta Pharma is dedicated to the development of better treatments for endometriosis patients, with promising preclinical data for vipoglanstat and a phase II study coming.